# Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer

> **NCT00239343** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 160 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** gefitinib

## Key facts

- **NCT ID:** NCT00239343
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2011-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239343, "Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00239343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*